Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.

Ahlén Bergman E, Hartana CA, Johansson M, Linton LB, Berglund S, Hyllienmark M, Lundgren C, Holmström B, Palmqvist K, Hansson J, Alamdari F, Huge Y, Aljabery F, Riklund K, Winerdal ME, Krantz D, Zirakzadeh AA, Marits P, Sjöholm LK, Sherif A, Winqvist O.

Clin Epigenetics. 2018 Aug 3;10(1):102. doi: 10.1186/s13148-018-0536-6.

2.

Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer.

Krantz D, Hartana CA, Winerdal ME, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Zirakzadeh AA, Holmström B, Riklund K, Sherif A, Winqvist O.

Eur Urol. 2018 Dec;74(6):688-692. doi: 10.1016/j.eururo.2018.06.048. Epub 2018 Jul 17.

PMID:
30025882
3.

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer.

Hartana CA, Ahlén Bergman E, Broomé A, Berglund S, Johansson M, Alamdari F, Jakubczyk T, Huge Y, Aljabery F, Palmqvist K, Holmström B, Glise H, Riklund K, Sherif A, Winqvist O.

Clin Exp Immunol. 2018 Oct;194(1):39-53. doi: 10.1111/cei.13183. Epub 2018 Aug 24.

4.

Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.

Hartana CA, Ahlén Bergman E, Zirakzadeh AA, Krantz D, Winerdal ME, Winerdal M, Johansson M, Alamdari F, Jakubczyk T, Glise H, Riklund K, Sherif A, Winqvist O.

PLoS One. 2018 Jul 2;13(7):e0200079. doi: 10.1371/journal.pone.0200079. eCollection 2018.

5.

Association between cancer risk and polycyclic aromatic hydrocarbons' exposure in the ambient air of Ahvaz, southwest of Iran.

Goudarzi G, Geravandi S, Alavi N, Idani E, Salmanzadeh S, Yari AR, Jamshidi F, Mohammadi MJ, Ranjbarzadeh A, Alamdari FA, Darabi F, Rohban A.

Int J Biometeorol. 2018 Aug;62(8):1461-1470. doi: 10.1007/s00484-018-1543-1. Epub 2018 Jun 29.

PMID:
29959528
6.

Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.

Winerdal ME, Krantz D, Hartana CA, Zirakzadeh AA, Linton L, Bergman EA, Rosenblatt R, Vasko J, Alamdari F, Hansson J, Holmström B, Johansson M, Winerdal M, Marits P, Sherif A, Winqvist O.

Cancer Immunol Res. 2018 May;6(5):528-538. doi: 10.1158/2326-6066.CIR-17-0466. Epub 2018 Mar 27.

7.

Health risk assessment on human exposed to heavy metals in the ambient air PM10 in Ahvaz, southwest Iran.

Goudarzi G, Alavi N, Geravandi S, Idani E, Behrooz HRA, Babaei AA, Alamdari FA, Dobaradaran S, Farhadi M, Mohammadi MJ.

Int J Biometeorol. 2018 Jun;62(6):1075-1083. doi: 10.1007/s00484-018-1510-x. Epub 2018 Feb 20.

PMID:
29464337
8.

Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.

Rosenblatt R, Johansson M, Alamdari F, Sidiki A, Holmström B, Hansson J, Vasko J, Marits P, Gabrielsson S, Riklund K, Winqvist O, Sherif A.

World J Urol. 2017 Jun;35(6):921-927. doi: 10.1007/s00345-016-1952-x. Epub 2016 Oct 13.

9.

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

Hartana CA, Kinn J, Rosenblatt R, Anania S, Alamdari F, Glise H, Sherif A, Winqvist O.

Br J Cancer. 2016 Oct 11;115(8):957-966. doi: 10.1038/bjc.2016.279. Epub 2016 Sep 6.

10.

Angiogenesis and other markers for prediction of survival in metastatic renal cell carcinoma.

Alamdari FI, Rasmuson T, Grankvist K, Ljungberg B.

Scand J Urol Nephrol. 2007;41(1):5-9.

PMID:
17366095
11.

Adrenal metastasis in renal cell carcinoma: a recommendation for adjustment of the TNM staging system.

Alamdari FI, Ljungberg B.

Scand J Urol Nephrol. 2005;39(4):277-82.

PMID:
16118103
12.
13.

Prognostic significance of the Heidelberg classification of renal cell carcinoma.

Ljungberg B, Alamdari FI, Stenling R, Roos G.

Eur Urol. 1999 Dec;36(6):565-9.

PMID:
10559609
14.
15.

Radical nephrectomy is still preferable in the treatment of localized renal cell carcinoma. A long-term follow-up study.

Ljungberg B, Alamdari FI, Holmberg G, Granfors T, Duchek M.

Eur Urol. 1998;33(1):79-85.

PMID:
9471045

Supplemental Content

Loading ...
Support Center